Blueprint Medicines Corporation (BPMC)

NASDAQ: BPMC · IEX Real-Time Price · USD

110.36

+1.18 (1.08%)

At close: Jul 2, 2024, 4:00 PM

109.00

-1.36 (-1.23%)

After-hours: Jul 2, 2024, 4:56 PM EDT

Blueprint Medicines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-506.98	-557.52	-644.09	313.88	-347.69	Upgrade
Depreciation & Amortization	20.77	20.1	12.79	12.35	10.25	Upgrade
Share-Based Compensation	92.67	98.97	91.63	75.53	54.65	Upgrade
Other Operating Activities	-43.31	-63.83	241.02	-14.72	4.78	Upgrade
Operating Cash Flow	-436.85	-502.28	-298.65	387.04	-278.02	Upgrade
Capital Expenditures	-16.06	-8.92	-3.09	-3.16	-14.01	Upgrade
Acquisitions	0	0	-258.15	0	0	Upgrade
Change in Investments	290.1	-140.33	35.38	-431.09	-2.45	Upgrade
Other Investing Activities	-	-0.29	-	-	-	Upgrade
Investing Cash Flow	274.04	-149.54	-225.86	-434.25	-16.47	Upgrade
Share Issuance / Repurchase	21.34	8.2	50.72	617.76	340.75	Upgrade
Debt Issued / Paid	97.93	137.79	0	0	0	Upgrade
Other Financing Activities	-0.04	415.83	-	-	-0.12	Upgrade
Financing Cash Flow	119.23	561.81	50.72	617.76	340.64	Upgrade
Exchange Rate Effect	0.2	-0.21	-0.89	-0.35	0.02	Upgrade
Net Cash Flow	-43.58	-90.01	-473.8	570.55	46.16	Upgrade
Free Cash Flow	-452.91	-511.2	-301.74	383.88	-292.03	Upgrade
Free Cash Flow Margin	-181.61%	-250.54%	-167.56%	48.36%	-439.06%	Upgrade
Free Cash Flow Per Share	-7.48	-8.57	-5.16	7.04	-6.11	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).